2007
Jan Andreas Burger, MD
M.D. Anderson Cancer Center, Houston, TX
Phosphoinositide 3-Kinases in Chemokine Receptor Signaling in Chronic Lymphocytic Leukemia
Made Possible by Mary Jo and John Boler
In Memory of Helen DeGulis
Javier Pinilla-Ibarz, MD, PhD
H. Lee Moffitt Cancer Center, Tampa, FL
Correlative Immunological Studies of a Pilot Trial With a WTl Analog Peptide Vaccine in
Patients With Myeloid Malignancies
Made Possible by Mary Jo and John Boler
In Memory of Richard J. Giffels
Monica Buzzai, PhD
Northwestern University Feinberg School of Medicine, Chicago, IL
Cell Survival and Proliferation Pathways Mediated by JAK2 Mutations in
Myeloproliferative Disorders (MPD) and Leukemia
Made Possible by Mary Jo and John Boler
In Memory of Patricia Winkel
B. Belinda Ding, PhD
Albert Einstein College of Medicine, Bronx, NY
Mechanism of STAT3 Activation in Diffuse Large B-cell Lymphoma
Made Possible by Ford Motor Company and
The Johnny Mercer Foundation
In Memory of Johnny Mercer
|
Ramiro Garzon, MD
The Ohio State University, Columbus, OH
Role of MicroRNA in the Pathogenesis of Acute Myeloid Leukemia
Made Possible by the Friends of José Carreras International Leukemia Foundation
Rosa Catera, PhD
The Feinstein Institute for Medical Research
North Shore – LIJ Health System, Manhasset, NY
Bacterial Components as Epitopes for B-CLL Antibodies
Made Possible by the Ambassador Felix Schnyder Memorial Fund
In Memory of Ambassador Felix Schnyder
Timothy S. Pardee, MD, PhD
Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
In Vitro Array Based Screening for Genes Involved in Chemoresistance and
Sensitivity in Acute Myelogenous Leukemia
Made Possible by the Ambassador Felix Schnyder Memorial Fund
In Memory of Ambassador Felix Schnyder |
